expected to grow at
30.46 percent CAGR to
reach USD 100 billion by
2025. The Biotechnology
Industry in India has
grown from $1.1 billion in
2005 to $7 billion in 2015
and is expected to reach
$11.6 billion in 2017. The
sector is divided into five
major segments- bio-
pharma, bio-services,
bio-agri, bio-industrial
and bio-informatics.
This conference has
potential to contribute
in the bio-pharma and
bio-industrial sectors
in a major way. The
National Biotechnology
Development Strategy
(2015-2020) aims to
create India as a world
class bio manufacturing
hub. India constitutes
around 8 percent of the
total global generics
market, by volume
indicating a huge
untapped opportunity
in the sector.
Apart from discussing
various applications of
biological engineering,
other collateral outcomes
of this conference were
launching of a new Indian
competition, similar
to that of MIT, USA,
announcement of a new
not-for-profit society
for training, networking
and intellectual
property generation.
BIOVOICENEWS.COM
59